Your session is about to expire
← Back to Search
Time-restricted Eating for Metabolic Disorders (READY Trial)
READY Trial Summary
This trial will study whether a new cancer prevention program can help reduce breast cancer risk factors.
READY Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.READY Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a job that requires you to work at night or rotate shifts.You have never had cancer before.Women. (Note: This criterion needs more context to provide a clear summary.)You have experienced an eating disorder and have reported it yourself.You have Type 1 diabetes.You have made significant changes to your diet in the past three months, such as counting calories or following a ketogenic diet.You are currently taking insulin, sulfonylureas, or GLP-1 receptor agonists for diabetes.You have a smartphone that can connect to other devices using Bluetooth and runs on either Apple or Android operating system.You have been eating less than three meals a day or within a 12-hour period consistently for the past three months.
- Group 1: Personalized TRE protocol + Peer Support
- Group 2: Personalized TRE protocol + External Support
- Group 3: Control Group
- Group 4: Standardized TRE protocol + External Support
- Group 5: Standardized TRE protocol + Peer Support
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new participants being welcomed for this clinical experiment?
"Clinicaltrials.gov reports that this clinical trial, which was initiated on the 7th of July 2022, is presently recruiting participants. The listing was last amended on the 11th of July 2022."
How many participants are signing up to be part of this experiment?
"Affirmative. According to information hosted on clinicaltrials.gov, this trial is presently in need of patient recruitment and was posted online on July 7th 2022. The most recent edit was made five days later, with the ultimate goal being 178 participants at a single location."
What are the fundamental aims of this research endeavor?
"This clinical trial will run for 16 Weeks, with the primary outcome being compliance to a TRE program. Secondary indicators of success include HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), physical activity monitored via FitBit Inspire 2 over 7 days, and Metabolic syndrome as defined by NCEP/ATP III criteria."
Share this study with friends
Copy Link
Messenger